{"id":"NCT00659373","sponsor":"ETOP IBCSG Partners Foundation","briefTitle":"Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02","officialTitle":"Investigating Cognitive Function for Patients Participating in the SOFT Trial in Selected Centers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2014-12","completion":"2016-04","firstPosted":"2008-04-16","resultsPosted":"2016-07-25","lastUpdate":"2016-07-25"},"enrollment":86,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":null},"conditions":["Breast Cancer","Fatigue","Sleep Disorders"],"interventions":[{"type":"DRUG","name":"Tamoxifen","otherNames":["Nolvadex"]},{"type":"DRUG","name":"triptorelin","otherNames":["GnRH analogue","Trelstar Depot","Decapeptyl Depot"]},{"type":"DRUG","name":"Exemestane","otherNames":["Aromasin"]}],"arms":[{"label":"Tamoxifen","type":"ACTIVE_COMPARATOR"},{"label":"T+OFS","type":"EXPERIMENTAL"},{"label":"E+OFS","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Learning about the long-term effects of adjuvant tamoxifen (T), adjuvant tamoxifen with ovarian function suppression (T+OFS), and exemestane with ovarian function suppression (E+ OFS) on brain function may help doctors plan cancer treatment.\n\nPURPOSE: This study is looking at brain function in premenopausal women who are receiving adjuvant tamoxifen (T) alone against those receive adjuvant tamoxifen (T+OFS) or exemestane (E+OFS) with ovarian function suppression (OFS) for early-stage breast cancer on clinical trial IBCSG-2402.","primaryOutcome":{"measure":"Change in Cognitive Function Over 1 Year in Premenopausal Breast Cancer Patients Who Receive Adjuvant Tamoxifen (T) Alone Against Those Receive Adjuvant Tamoxifen (T+OFS) or Exemestane (E+OFS) With Ovarian Function Suppression (OFS)","timeFrame":"1 year after patient randomization to parent IBCSG 24-02 study","effectByArm":[{"arm":"Tamoxifen","deltaMin":-0.04,"sd":0.49},{"arm":"Ovarian Function Suppression","deltaMin":-0.21,"sd":0.92}],"pValues":[{"comp":"OG000 vs OG001","p":"0.71"}]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":15,"countries":["United States","Canada"]},"refs":{"pmids":["27092785"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":[]}}